FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2810415362> ?p ?o ?g. }

• W2810415362 abstract "Abstract Background and objective Primary cutaneous lymphomas are uncommon. This article describes the Primary Cutaneous Lymphoma Registry of the Spanish Academy of Dermatology and Venereology (AEDV) and reports on the results from the first year. Patients and methods Disease registry for patients with primary cutaneous lymphoma. The participating hospitals prospectively recorded data on diagnosis, treatment, tests, and disease stage for all patients with primary cutaneous lymphoma. A descriptive analysis was performed. Results In December 2017, the registry contained data on 639 patients (60% male) from 16 university hospitals. The most common diagnoses, in order of frequency, were mycosis fungoides/Sezary syndrome (MF/SS) (348 cases, 55%), primary cutaneous B-cell lymphoma (CBCL) (184 cases, 29%), primary cutaneous CD30+ T-cell lymphoproliferative disorder (CD30+ CLPD) (70 cases, 11%), and other types of T-cell lymphoma (37 cases, 5%). In total, 105 (16.5%) of the cases recorded were incident cases. The most common diagnosis in the MF/SS group was classic MF (77.3%). Half of the patients with MF had stage IA disease when diagnosed, and the majority were either in partial remission (32.5%) or had stable disease (33.1%). The most widely used treatments were topical corticosteroids (90.8%) and phototherapy. The most common form of primary CBCL was marginal zone lymphoma (50%). Almost all of the patients had cutaneous involvement only and nearly half had stage T1a disease. Most (76.1%) were in complete remission. The main treatments were surgery (55.4%) and radiotherapy (41.9%). The most common diagnosis in patients with CD30+ CLPD was lymphomatoid papulosis (68.8%). Most of the patients (31.4%) had stage T3b disease and half were in complete remission. The most common treatments were topical corticosteroids (68.8%) and systemic chemotherapy (32.9%). Conclusion The characteristics of patients with primary cutaneous lymphoma in Spain do not differ from those described in other series in the literature. The registry will facilitate clinical research by the AEDV's lymphoma group." @default.
• W2810415362 created "2018-07-10" @default.
• W2810415362 creator A5001858382 @default.
• W2810415362 creator A5004083884 @default.
• W2810415362 creator A5009226979 @default.
• W2810415362 creator A5014042753 @default.
• W2810415362 creator A5022514739 @default.
• W2810415362 creator A5023408839 @default.
• W2810415362 creator A5027681898 @default.
• W2810415362 creator A5027830025 @default.
• W2810415362 creator A5031719385 @default.
• W2810415362 creator A5032453432 @default.
• W2810415362 creator A5036263685 @default.
• W2810415362 creator A5038239972 @default.
• W2810415362 creator A5040002210 @default.
• W2810415362 creator A5040812031 @default.
• W2810415362 creator A5041803353 @default.
• W2810415362 creator A5042490224 @default.
• W2810415362 creator A5053459500 @default.
• W2810415362 creator A5054125403 @default.
• W2810415362 creator A5054741870 @default.
• W2810415362 creator A5058719864 @default.
• W2810415362 creator A5066299516 @default.
• W2810415362 creator A5068273256 @default.
• W2810415362 creator A5071001690 @default.
• W2810415362 creator A5072456059 @default.
• W2810415362 creator A5074999615 @default.
• W2810415362 creator A5081538785 @default.
• W2810415362 creator A5084643050 @default.
• W2810415362 creator A5085277777 @default.
• W2810415362 creator A5089238862 @default.
• W2810415362 creator A5090263713 @default.
• W2810415362 date "2018-09-01" @default.
• W2810415362 modified "2023-10-18" @default.
• W2810415362 title "The First Year of the AEVD Primary Cutaneous Lymphoma Registry" @default.
• W2810415362 cites W1495282143 @default.
• W2810415362 cites W1921666217 @default.
• W2810415362 cites W1976541396 @default.
• W2810415362 cites W2015828565 @default.
• W2810415362 cites W2025214085 @default.
• W2810415362 cites W2036837149 @default.
• W2810415362 cites W2058283401 @default.
• W2810415362 cites W2072784724 @default.
• W2810415362 cites W2096160655 @default.
• W2810415362 cites W2096455548 @default.
• W2810415362 cites W2131366328 @default.
• W2810415362 cites W2133878093 @default.
• W2810415362 cites W2140608535 @default.
• W2810415362 cites W2310716991 @default.
• W2810415362 cites W2546033842 @default.
• W2810415362 cites W2598355592 @default.
• W2810415362 cites W2762297532 @default.
• W2810415362 cites W2100103468 @default.
• W2810415362 doi "https://doi.org/10.1016/j.adengl.2018.06.003" @default.
• W2810415362 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29680323" @default.
• W2810415362 hasPublicationYear "2018" @default.
• W2810415362 type Work @default.
• W2810415362 sameAs 2810415362 @default.
• W2810415362 citedByCount "4" @default.
• W2810415362 countsByYear W28104153622020 @default.
• W2810415362 countsByYear W28104153622023 @default.
• W2810415362 crossrefType "journal-article" @default.
• W2810415362 hasAuthorship W2810415362A5001858382 @default.
• W2810415362 hasAuthorship W2810415362A5004083884 @default.
• W2810415362 hasAuthorship W2810415362A5009226979 @default.
• W2810415362 hasAuthorship W2810415362A5014042753 @default.
• W2810415362 hasAuthorship W2810415362A5022514739 @default.
• W2810415362 hasAuthorship W2810415362A5023408839 @default.
• W2810415362 hasAuthorship W2810415362A5027681898 @default.
• W2810415362 hasAuthorship W2810415362A5027830025 @default.
• W2810415362 hasAuthorship W2810415362A5031719385 @default.
• W2810415362 hasAuthorship W2810415362A5032453432 @default.
• W2810415362 hasAuthorship W2810415362A5036263685 @default.
• W2810415362 hasAuthorship W2810415362A5038239972 @default.
• W2810415362 hasAuthorship W2810415362A5040002210 @default.
• W2810415362 hasAuthorship W2810415362A5040812031 @default.
• W2810415362 hasAuthorship W2810415362A5041803353 @default.
• W2810415362 hasAuthorship W2810415362A5042490224 @default.
• W2810415362 hasAuthorship W2810415362A5053459500 @default.
• W2810415362 hasAuthorship W2810415362A5054125403 @default.
• W2810415362 hasAuthorship W2810415362A5054741870 @default.
• W2810415362 hasAuthorship W2810415362A5058719864 @default.
• W2810415362 hasAuthorship W2810415362A5066299516 @default.
• W2810415362 hasAuthorship W2810415362A5068273256 @default.
• W2810415362 hasAuthorship W2810415362A5071001690 @default.
• W2810415362 hasAuthorship W2810415362A5072456059 @default.
• W2810415362 hasAuthorship W2810415362A5074999615 @default.
• W2810415362 hasAuthorship W2810415362A5081538785 @default.
• W2810415362 hasAuthorship W2810415362A5084643050 @default.
• W2810415362 hasAuthorship W2810415362A5085277777 @default.
• W2810415362 hasAuthorship W2810415362A5089238862 @default.
• W2810415362 hasAuthorship W2810415362A5090263713 @default.
• W2810415362 hasBestOaLocation W28104153621 @default.
• W2810415362 hasConcept C126322002 @default.
• W2810415362 hasConcept C141071460 @default.
• W2810415362 hasConcept C146357865 @default.
• W2810415362 hasConcept C151730666 @default.
• W2810415362 hasConcept C16005928 @default.
• W2810415362 hasConcept C2776995267 @default.
• W2810415362 hasConcept C2777182591 @default.

• next